114 related articles for article (PubMed ID: 73061)
1. Immune complexes in myeloproliferative disorders.
Lewis CM; Pegrum GD
Lancet; 1977 Dec; 2(8049):1151-3. PubMed ID: 73061
[TBL] [Abstract][Full Text] [Related]
2. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
Loni C; Ricci S; Azzarà A; Bertoncini G
Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating neutrophils with surface receptor activity for immunoglobulin G in polycythemia vera and myeloid metaplasia.
Gilbert HS; Goldberg R; Ward L
Blood; 1979 Jun; 53(6):1106-13. PubMed ID: 444652
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis in myeloproliferative disorders.
Corberand J; LaHarrague P; De Larrard B; Nguyen F; Pris J
Am J Clin Pathol; 1980 Sep; 74(3):301-5. PubMed ID: 6932175
[TBL] [Abstract][Full Text] [Related]
5. [Criteria of differential diagnosis of chronic myeloproliferative diseases].
Shardakov VI; Kopaneva TG; Dem'ianova VT
Gematol Transfuziol; 1991 Jun; 36(6):3-4. PubMed ID: 1769495
[TBL] [Abstract][Full Text] [Related]
6. [Serum immunological abnormalities in myeloid splenomegaly and myelosclerosis].
Boivin P
Rev Roum Med Intern; 1973; 10(3):170-7. PubMed ID: 4123073
[No Abstract] [Full Text] [Related]
7. Immunologic dysfunction in the myeloproliferative disorders.
DiBella NJ; Brown GL
Cancer; 1978 Jul; 42(1):149-58. PubMed ID: 276412
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor VIII-related antigen in patients with chronic myeloproliferative disorders.
Takahashi H; Shibata A
Thromb Res; 1980 Aug; 19(3):423-7. PubMed ID: 6776651
[No Abstract] [Full Text] [Related]
9. Circulating high molecular weight IgG fibronectin complexes in myeloproliferative disorders.
Baglin TP; Price SM; Boughton BJ
J Clin Pathol; 1990 Feb; 43(2):102-5. PubMed ID: 2318985
[TBL] [Abstract][Full Text] [Related]
10. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of RNA-dependent platelet DNA polymerase in patients with myeloproliferative disorders.
Strayer DR; Brodsky I; Caranfa MJ; Gillespie DH
Br J Haematol; 1982 Mar; 50(3):521-30. PubMed ID: 6175335
[TBL] [Abstract][Full Text] [Related]
12. [MYELOPROLIFERATIVE DISORDERS].
MARCIACQ ALTAFULLA
Arch Med Panamenos; 1963 Aug; 12():149-59. PubMed ID: 14164997
[No Abstract] [Full Text] [Related]
13. Leukemia-associated antigens in leukemic transformation of polycythemia vera.
Pisciotta AV; Cronkite C; Hanson GA; Brodsky JB; Donovan PB; Wasserman LR
J Lab Clin Med; 1983 Mar; 101(3):432-40. PubMed ID: 6827175
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
15. Platelet Fc receptor. Increased expression in myeloproliferative disease.
Moore A; Nachman RL
J Clin Invest; 1981 Apr; 67(4):1064-71. PubMed ID: 6937475
[TBL] [Abstract][Full Text] [Related]
16. POLYCYTHAEMIA VERA: A CASE REPORT.
JACOBS P
Cent Afr J Med; 1963 Oct; 9():387-95. PubMed ID: 14066238
[No Abstract] [Full Text] [Related]
17. Subclinical immune complexes in the glomeruli of kidneys postmortem.
Sutherland JC; Markham RV; Mardiney MR
Am J Med; 1974 Oct; 57(4):536-41. PubMed ID: 4611206
[No Abstract] [Full Text] [Related]
18. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES].
STOBBE H
Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017
[No Abstract] [Full Text] [Related]
19. Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis.
Rondeau E; Solal-Celigny P; Dhermy D; Vroclans M; Brousse N; Bernard JF; Boivin P
Br J Haematol; 1983 Mar; 53(3):467-75. PubMed ID: 6824588
[TBL] [Abstract][Full Text] [Related]
20. [On the existence of a myeloproliferative factor in patients with a myeloproliferative syndrome (author's transl)].
Essers U; Nowak H
Blut; 1979 Aug; 39(2):107-15. PubMed ID: 289427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
